Your browser doesn't support javascript.
loading
Association of Health-Related Quality of Life with Overall Survival in Older Americans with Kidney Cancer: A Population-Based Cohort Study.
Bhandari, Naleen Raj; Kamel, Mohamed H; Kent, Erin E; McAdam-Marx, Carrie; Ounpraseuth, Songthip T; Tilford, J Mick; Payakachat, Nalin.
Afiliación
  • Bhandari NR; Division of Pharmaceutical Evaluation and Policy, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR 72205, USA.
  • Kamel MH; Department of Urology, University of Cincinnati, Cincinnati, OH 45221, USA.
  • Kent EE; Department of Urology, Ain Shams University, Cairo 11566, Egypt.
  • McAdam-Marx C; Department of Health Policy and Management, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
  • Ounpraseuth ST; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27514, USA.
  • Tilford JM; Department of Pharmacy Practice and Science, University of Nebraska Medical Center, Omaha, NE 68198, USA.
  • Payakachat N; Department of Biostatistics, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR 72205, USA.
Healthcare (Basel) ; 9(10)2021 Oct 10.
Article en En | MEDLINE | ID: mdl-34683025
BACKGROUND: Our purpose was to evaluate associations between health-related quality of life (HRQoL) and overall survival (OS) in a population-based sample of kidney cancer (KC) patients in the US. METHODS: We analyzed a longitudinal cohort (n = 188) using the Surveillance, Epidemiology, and End Results (SEER) database linked with the Medicare Health Outcomes Survey (MHOS; 1998-2014). We included KC patients aged ≥65 years, with a completed MHOS during baseline (pre-diagnosis) and another during follow-up (post-diagnosis). We reported HRQoL as physical component summary (PCS) and mental component summary (MCS) scores and OS as number of months from diagnosis to death/end-of-follow-up. Findings were reported as adjusted hazard ratios (aHRs (95% CI)) from Cox Proportional Hazard models. RESULTS: The aHRs associated with a 3-point lower average (baseline and follow-up) or a 3-point within-patient decline (change) in HRQoL with OS were: (a) baseline: PCS (1.08 (1.01-1.16)) and MCS (1.09 (1.01-1.18)); (b) follow-up: PCS (1.21 (1.12-1.31)) and MCS (1.11 (1.04-1.19)); and (c) change: PCS (1.10 (1.02-1.18)) and MCS (1.02 (0.95-1.10)). CONCLUSIONS: Reduced HRQoL was associated with worse OS and this association was strongest for post-diagnosis PCS, followed by change in PCS and pre-diagnosis PCS. Findings highlight the prognostic value of HRQoL on OS, emphasize the importance of monitoring PCS in evaluating KC prognosis, and contribute additional evidence to support the implementation of patient-reported outcomes in clinical settings.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Healthcare (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Idioma: En Revista: Healthcare (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza